Press release from Companies: RhoVac's CEO, Anders Månsson, has tendered his resignation

Press release from Companies: RhoVacs VD, Anders Månsson, har lämnat in sin avskedsansökan

Press release from Companies: RhoVac terminates its stock liquidity provision service and announces the last day for trading in the convertible

Press release from Companies: RhoVac avslutar tjänst om likviditetsgaranti i aktien och meddelar om sista dag för handel med konvertibeln

Market Notices: Market Notice 119/22 – Last day of trading in Rhovac AB’s convertible bond

Press release from Companies: RhoVac provides a status update and investigates a potentially accelerated repayment of the convertible loan

Press release from Companies: RhoVac ger statusuppdatering och undersöker förutsättningarna för en accelererad återbetalning av konvertibellånet

Market Notices: Market notice 94/22 – RhoVac AB´s financial instruments are moved to the Observation List

Press release from Companies: RhoVac’s phase IIb study in prostate cancer , BRaVac, failed to meet its primary endpoint

Press release from Companies: RhoVacs fas IIb-studie, BRaVac, lyckades inte nå sin "Primary Endpoint"

Press release from Companies: Pre-clinical findings support the potential use of RhoVac’s drug candidate, onilcamotide, across several cancers

Press release from Companies: Pre-clinical findings support the potential use of RhoVac’s drug candidate, onilcamotide, across several cancers